Bactrim and Tapazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bactrim (sulfamethoxazole; trimethoprim) and Tapazole (methimazole). Common drug interactions include dysgeusia among females and atrial fibrillation among males.

The phase IV clinical study analyzes what interactions people have when they take Bactrim and Tapazole. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Bactrim?

Bactrim has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 89,117 Bactrim users. Check the latest studies of Bactrim.

What is Tapazole?

Tapazole has active ingredients of methimazole. It is often used in hyperthyroidism. eHealthMe is studying from 2,477 Tapazole users. Check the latest studies of Tapazole.



On Jul, 23, 2026

19 people who take Bactrim and Tapazole together, and have interactions are studied.

Bactrim and Tapazole drug interactions.

What are the common drug interactions of Bactrim and Tapazole, by gender? *:

female:

  1. Dysgeusia (disorder of the sense of taste)
  2. Hypoaesthesia (reduced sense of touch or sensation)
  3. Nausea (feeling of having an urge to vomit)
  4. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  5. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  6. Pulse absent
  7. Pyrexia (fever)
  8. Rheumatoid vasculitis (inflammation of veins with painful joints and morning stiffness)
  9. Urticaria (rash of round, red welts on the skin that itch intensely)
  10. Weight decreased

male:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Death
  3. Facial bones fracture (bone fracture of face)
  4. Neuropathy peripheral (surface nerve damage)

What are the common drug interactions of Bactrim and Tapazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  2. Nephrogenic fibrosing dermopathy (involves fibrosis of skin, joints, eyes due to kidney disease)

40-49:

  1. Drug hypersensitivity
  2. Urticaria (rash of round, red welts on the skin that itch intensely)

50-59:

n/a

60+:

  1. Cough
  2. Dyspnoea (difficult or laboured respiration)
  3. Pulse absent
  4. Rheumatoid vasculitis (inflammation of veins with painful joints and morning stiffness)
  5. Weight decreased
  6. Angiopathy (generic term for a disease of the blood vessels)
  7. Arrhythmia (irregular heartbeat)
  8. Arterial embolism limb
  9. Arterial thrombosis limb (formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system-limb)
  10. Arthralgia (joint pain)

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 3 people, 15.79%
  2. Multiple Myeloma (cancer of the plasma cells): 3 people, 15.79%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 10.53%
  4. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 10.53%
  5. Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 2 people, 10.53%
  6. Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 10.53%
  7. Weight Decreased: 1 person, 5.26%
  8. Type 2 Diabetes: 1 person, 5.26%
  9. Stress And Anxiety: 1 person, 5.26%
  10. Skin Discoloration: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Bactrim and Tapazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Bactrim and Tapazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Bactrim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tapazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bactrim and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tapazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sulfamethoxazole; trimethoprim and methimazole (the active ingredients of Bactrim and Tapazole, respectively), and Bactrim and Tapazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: